Sign in

CIK 0001082554

  • Large accelerated filer

UNITED THERAPEUTICS Corp

Sign in to watch
Ticker
UTHR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
521984749
Phone
+1 301-608-9292
Business address
1000 SPRING ST, SILVER SPRING, MD, 20910
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $530.57 ($5,040,380)
  10. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $532.24 ($5,056,298)
  11. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $531.69 ($5,051,035)
  12. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $537.05 ($5,101,939)
  13. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $530.91 ($5,043,689)
  14. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $530.35 ($5,038,340)
  15. 4 Planned sale EVP & GENERAL COUNSEL sold 8,300 shares at an average $533.69 ($4,429,638)
  16. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $526.83 ($5,004,909)
  17. 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $535.99 ($5,091,949)
  18. 4 Exercise or conversion Director acquired 1,310 shares (option exercise)
  19. 4 Exercise or conversion Director acquired 650 shares (option exercise)
  20. 4 Exercise or conversion Director acquired 650 shares (option exercise)

Page 6 of 164 · 3,269 filings